is mounjaro same as tirzepatide Injection Mounjaro (tirzepatide): Dual-Action Diabetes and

: ( ) 1 (1 ) , 30

"More females over males

Key therapeutic benefits include: Significant reductions in HbA1c (up to 2.02.5% in clinical trials) Substantial weight loss (up to 15% body weight reduction in type 2 diabetes and up to 22% in people without diabetes at the 15 mg dose) Cardiovascular risk factor improvements Once-weekly dosing for improved adherence Tirzepatide is not indicated for type 1 diabetes and should be used with caution or avoided in pregnancy and breastfeeding

Excessive NO disrupts ER Ca 2+ homeostasis, leading to impaired protein folding and metabolite-derived redox imbalance